The business's revenue was down 8.2% compared to the same quarter past year. Gilead Sciences Inc (Put) now has $94.80B valuation. Cable Hill Partners LLC now owns 1,584 shares of the biopharmaceutical company's stock worth $107,000 after buying an additional 541 shares during the last quarter. These shares are worth $5,563,041 and were traded at $75.86 each.
Gilead Sciences (NASDAQ:GILD) last posted its quarterly earnings results on Wednesday, July 26th. It has underperformed by 38.50% the S&P500.
Corda Investment Management Llc decreased Deere & Co Com (DE) stake by 4.39% reported in 2016Q4 SEC filing. It increased, as 30 investors sold Dril-Quip, Inc. shares while 76 reduced holdings. The Highstreet Asset Management Inc holds 10,423 shares with $746,000 value, down from 17,731 last quarter. Over the past five trading sessions it is 3.33%; 10.21% for the month; -0.98% for the last quarter; -12.45% for the past six-months; and 11.33% for the last 12 months. About 4,053 shares traded.
On July 26, 2017 Redburn initiated coverage on the stock giving it an initial rating of "Buy". Therefore 63% are positive.
Analysts have a consensus rating of 2.50 on the stock. (GILD) traded down 1.052% during trading on Friday, reaching $71.935. As per Monday, September 12, the company rating was initiated by Berenberg. Maxim Group maintained the stock with "Hold" rating in Tuesday, May 30 report. Also, EVP Gregg H. Alton sold 40,000 shares of the company's stock in a transaction that occurred on Friday, July 21st. BidaskClub downgraded Gilead Sciences from a "buy" rating to a "hold" rating in a report on Wednesday. Barclays PLC restated an "overweight" rating and set a $85.00 price objective (down from $90.00) on shares of Gilead Sciences in a research note on Sunday, April 23rd. The rating was maintained by Cowen & Co with "Buy" on Tuesday, July 25. The firm has "Equal-Weight" rating by Morgan Stanley given on Tuesday, April 19. (NASDAQ:GILD) has "Hold" rating given on Wednesday, August 31 by Jefferies.
Investors sentiment decreased to 0.7 in Q4 2016. Its down 0.89, from 2.2 in 2016Q3. 111 funds opened positions while 421 raised stakes.
Analysts on average have given a price target of $79.68 to Gilead Sciences Inc. Tower Rech Capital Ltd Com (Trc) invested in 0% or 340 shares.
COPYRIGHT VIOLATION WARNING: "Schwab Charles Investment Management Inc". (NASDAQ:GILD), Stochastic %D value stayed at 25.27% for the last 9 days. Boston Prtn holds 0.98% or 10.40 million shares in its portfolio. Williams Jones And Associate Limited Liability Corp reported 6,760 shares. Now the P/E of Gilead Sciences Inc. TFS Capital LLC raised its stake in shares of Gilead Sciences by 1.4% in the first quarter. (NASDAQ:GILD). 53,036 were reported by Ferguson Wellman Mngmt. The North Carolina-based Westend Limited Liability Company has invested 0% in Gilead Sciences, Inc. Cypress Cap Management Limited Liability Corporation (Wy) owns 0% invested in Gilead Sciences, Inc. Tudor Invest Corp Et Al has invested 0.01% of its portfolio in Oclaro, Inc.
Since February 23, 2017, it had 0 insider buys, and 9 sales for $22.97 million activity. Cogan John Francis had sold 9,943 shares worth $668,667 on Tuesday, May 9. 73,333 shares valued at $4.78 million were sold by MARTIN JOHN C on Thursday, June 1. (NASDAQ:GILD) or 20,365 shares. Grade Corp Bd Etf (LQD) stake by 8,243 shares and now owns 23,441 shares. Johnson & Johnson (NYSE:JNJ) was raised too.
Investors sentiment increased to 20.4 in Q4 2016. Its up 0.11, from 0.75 in 2016Q3. It dived, as 33 investors sold TRMB shares while 124 reduced holdings. 21 funds opened positions while 81 raised stakes. Homrich And Berg invested in 0.02% or 3,537 shares. Kcg Inc reported 0.01% stake. Employees Retirement Association Of Colorado owns 52,875 shares. Sumitomo Mitsui Asset Mgmt stated it has 99,569 shares. Temasek (Private) invested in 13.83M shares. Sequoia Fincl Advsrs Limited Company holds 0.74% in Gilead Sciences, Inc. Fil holds 0.09% or 1.06 million shares. Essex Finance Serv accumulated 27,640 shares. Hennessy Advisors owns 20,943 shares or 0.04% of their United States portfolio. When we look at the Volatility of the company, Week Volatility is at 1.86% whereas Month Volatility is at 1.54%. National Pension accumulated 926,786 shares. Quantbot Tech L P has invested 0.04% of its portfolio in Dril-Quip, Inc.
In an overview of the current analyst recommendations, Buy count is 11 and Overweight is 3 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Therefore 100% are positive. Novavax had 16 analyst reports since August 11, 2015 according to SRatingsIntel.
More notable recent Gilead Sciences, Inc. The company was maintained on Thursday, November 19 by Northland Capital. The consensus rating is 2.5, suggesting the market has given up on the stock. The firm has "Outperform" rating given on Friday, December 18 by Barrington Research. On Wednesday, February 3 the stock rating was maintained by Oppenheimer with "Outperform". The firm earned "Neutral" rating on Wednesday, February 8 by Citigroup. Ladenburg Thalmann downgraded Novavax, Inc. Goldman Sachs upgraded the stock to "Buy" rating in Friday, June 3 report. Wunderlich maintained it with "Buy" rating and $57.0 target in Thursday, August 13 report.
Since February 28, 2017, it had 8 buys, and 2 insider sales for $59,360 activity. Beta factor was calculated at 1.23. ARS Investment Partners LLC now owns 5,610 shares of the biopharmaceutical company's stock valued at $381,000 after buying an additional 50 shares during the period.